Glioblastoma stem cells and Wnt signaling pathway: Molecular mechanisms and therapeutic targets

被引：29
作者：
Guan R. [1 ]
Zhang X. [2 ]
Guo M. [1 ]
机构：
[1] Department of Neurosurgery, Second Affiliated Hospital, Harbin Medical University, 246 Xuefu Road, Nangang, Harbin, Heilongjiang Province
[2] Department of Neurology, Second Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang Province
来源：
Chinese Neurosurgical Journal | / 6卷 / 1期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1186/s41016-020-00207-z
中图分类号：
学科分类号：
摘要：
Glioblastoma is the most common form of primary brain tumor. Glioblastoma stem cells play an important role in tumor formation by activation of several signaling pathways. Wnt signaling pathway is one such important pathway which helps cellular differentiation to promote tumor formation in the brain. Glioblastoma remains to be a highly destructive type of tumor despite availability of treatment strategies like surgery, chemotherapy, and radiation. Advances in the field of cancer biology have revolutionized therapy by allowing targeting of tumor-specific molecular deregulation. In this review, we discuss about the significance of glioblastoma stem cells in cancer progression through Wnt signaling pathway and highlight the clinical targets being potentially considered for therapy in glioblastoma. © 2020 The Author(s).
引用
收藏
相关论文
共 77 条
  • [31] Ulasov I.V., Nandi S., Dey M., Sonabend A.M., Lesniak M.S., Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy, Molecular Medicine (Cambridge, Mass), 17, 1-2, pp. 103-112, (2011)
  • [32] Liong C., Ortiz D., Ao-Ieong E., Navati M.S., Friedman J.M., Cabrales P., Localized increase of tissue oxygen tension by magnetic targeted drug delivery, Nanotechnology, 25, 26, (2014)
  • [33] Gillespie D.L., Aguirre M.T., Ravichandran S., Leishman L.L., Berrondo C., Gamboa J.T., Wang L., King R., Wang X., Tan M., Et al., RNA interference targeting hypoxia-inducible factor 1alpha via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model, J Neurosurg, 122, 2, pp. 331-341, (2015)
  • [34] Wang C.H., Chiou S.H., Chou C.P., Chen Y.C., Huang Y.J., Peng C.A., Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody, Nanomedicine, 7, 1, pp. 69-79, (2011)
  • [35] Wu Z.B., Qiu C., Zhang A.L., Cai L., Lin S.J., Yao Y., Tang Q.S., Xu M., Hua W., Chu Y.W., Et al., Glioma-associated antigen HEATR1 induces functional cytotoxic T lymphocytes in patients with glioma, J Immunol Res, 2014, (2014)
  • [36] Li W.Q., Li Y.M., Tao B.B., Lu Y.C., Hu G.H., Liu H.M., He J., Xu Y., Yu H.Y., Downregulation of ABCG2 expression in glioblastoma cancer stem cells with miRNA-328 may decrease their chemoresistance, Med Sci Monit, 16, 10, pp. Hy27-Hy30, (2010)
  • [37] Martin V., Sanchez-Sanchez A.M., Herrera F., Gomez-Manzano C., Fueyo J., Alvarez-Vega M.A., Antolin I., Rodriguez C., Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells, Brit J Cancer, 108, 10, pp. 2005-2012, (2013)
  • [38] Wu J., Lai G., Wan F., Xiao Z., Zeng L., Wang X., Ye F., Lei T., Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells, Tohoku J Exp Med, 226, 4, pp. 267-274, (2012)
  • [39] Nadkarni A., Shrivastav M., Mladek A.C., Schwingler P.M., Grogan P.T., Chen J., Sarkaria J.N., ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cells, J Neuro-oncol, 110, 3, pp. 349-357, (2012)
  • [40] King H.O., Brend T., Payne H.L., Wright A., Ward T.A., Patel K., Egnuni T., Stead L.F., Patel A., Wurdak H., Et al., RAD51 Is a selective DNA repair target to radiosensitize glioma stem cells, Stem Cell Reports, 8, 1, pp. 125-139, (2017)
12345678